Table 4 – Characteristicsa of 277 participants with a baseline reading of ACR ≤35 mg/mmol2 by follow-up ACRc
From: Clinical outcomes associated with albuminuria in central Australia: a cohort study
All participants | Green/normal risk category (ACR <3.5) | Yellow/mild risk category (ACR 3.5-35) | Red/high risk category (ACR >35) | |
|---|---|---|---|---|
(n = 277) | (n = 139) | (n = 93) | (n = 45) | |
Age at recruitment | 31 (15–74) | 29 (16–70) | 33 (15–70) | 30 (16–74) |
Age at exit | 40 (19–80) | 40 (19–75) | 41 (22–80) | 40 (23–80) |
Male gender | 127 (45.9) | 66 (47.5) | 45 (48.4) | 16 (35.6) |
Alcohol abstinence | 166 (61.3) | 88 (63.8) | 48 (53.3) | 30 (69.8) |
Current smoker | 78 (28.9) | 39 (28.3) | 28 (31.5) | 11 (25.6) |
Diabetes | 42 (15.2) | 9 (6.5) | 18 (19.4) | 12 (33.3) |
BMI, kg/mb | 25.8 (14.6-48.4) | 24.8 (14.6-44.1) | 26.4 (16.7-46.2) | 26.9 (19.6-48.4) |
WHR | 0.87 (0.70-1.33) | 0.85 (0.70-1.04) | 0.89 (0.70-1.33) | 0.91 (0.78-1.03) |
Hypertension | 53 (19.1) | 25 (18.0) | 17 (18.3) | 11 (24.4) |
Systolic BP, mmHg | 125 (93–184) | 124 (93–134) | 125 (96–184) | 127 (103–164) |
Diastolic BP, mmHg | 71 (44–108) | 71 (45–108) | 70 (44–105) | 72 (53–100) |
Homocysteine, μM | 13.8 (4.0-46.1) | 13.2 (6.3-46.1) | 14.6 (7.0-37.9) | 12.4 (3.4-41.1) |
Prevalent UTI | 14 (5.1) | 7 (5.0) | 4 (4.3) | 3 (6.7) |